Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Endometriosis × relugolix × Clear all

Phase

Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 5 Prostatic Neoplasms 4 Menorrhagia 3 Myofibroma 2 Prostate Adenocarcinoma 1 Endometriosis 1

Interventions

relugolix 1 Immunonutrition Diet 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05862272 2025-08-06

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

Sumitomo Pharma Switzerland GmbH

Phase 3 Recruiting

Endometriosis, Leiomyoma, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡